Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny “decoy” implanted just beneath the skin, University of Michigan researchers have demonstrated in mice.
These devices have a knack for attracting cancer cells traveling through the body. In fact, they can even pick up signs that cancer is preparing to spread, before cancer cells arrive.
“Biopsying an organ like the lung is a risky procedure that’s done only sparingly,” said Lonnie Shea, the William and Valerie Hall Chair of biomedical engineering at U-M. “We place these scaffolds right under the skin, so they’re readily accessible.”
The ease of access would also allow doctors to monitor the effectiveness of cancer treatments closer to real time.
The U-M team’s most recent work appears in Cancer Research, a publication of the American Association for Cancer Research.
Biopsies of the scaffold allowed researchers to analyze 635 genes present in the captured cancer cells. From these genes, the team identified ten that could predict whether a mouse was healthy, if it had a cancer that had not begun to spread yet, or if a cancer was present and had begun to spread. They could do that all without the need for an invasive biopsy of an organ.
The gene expression obtained at the scaffold had distinct patterns relative to cells from the blood, which are obtained through a technique known as liquid biopsy. These differences highlight that the tissue in these traps provides unique information that correlates with disease progression.
The researchers have demonstrated that the synthetic scaffolds work with multiple types of cancers in mice, including pancreatic cancer. They work by luring immune cells, which, in turn, attract cancer cells.
“When we started off, the idea was that we would biopsy the scaffold and look for tumor cells that had followed the immune cells there,” Shea said. “But we realized that by analyzing the immune cells that gather first, we can detect the cancer before it’s spreading.”
In treating cancer, early detection is key.
“Currently, early signs of metastasis can be difficult to detect,” said Jacqueline Jeruss, an associate professor of surgery and biomedical engineering and a co-author of the study. “Imaging may be done once a patient experiences symptoms, but that implies the number of cancer cells may already be substantial. Improved detection methods are needed to identify metastasis at a point when targeted treatments can have a significant beneficial impact on slowing disease progression.”
The immune cells allowed researchers to identify whether treatments were effective in the mice and which subjects were sensitive or resistant to treatment.
The decoy’s ability to draw immune and cancer cells can also bolster the treatment itself. In previous research, the devices demonstrated an ability to slow the growth of metastatic breast cancer tumors in mice, by reducing the number of cancer cells that can reach those tumors.
In the future, Shea envisions that the scaffolds could be outfitted with sensors and Bluetooth technology that could deliver information in real time without the need for a biopsy.
The Latest on: Biopsies
via Google News
The Latest on: Biopsies
- Neuro-navigation Systems Market Outlook 2018 : Size, Business Demand and Trends : To Witness a Pronounce Growth : Forecasts Till 2026 on November 18, 2019 at 12:43 am
Moreover, these systems are also used during performing brain biopsies in the removal of the tumor through open brain surgery is difficult and life-threatening. The most important function of the ...
- 3 Medtech Earnings Winners on November 17, 2019 at 11:00 pm
In this week's episode of Industry Focus: Healthcare, host Shannon Jones talks with Motley Fool medtech guru Brian Feroldi about three earnings reports from three fantastic medtech companies: Guardant ...
- Larry Goldenberg: Checking PSA is not stepping onto a slippery slope to inevitable biopsies on November 15, 2019 at 6:02 pm
But simply checking PSA is not stepping onto a slippery slope to inevitable biopsies, surgery, radiation and chemotherapy; it is just a single decision point. PSA screening is like a fishing ...
- Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market Report Is Covering Marketing Strategies, Prognosis and Main Vendors on November 15, 2019 at 8:22 am
Other factors that should be taken into account are rising preference towards targeted therapy use in cancer treatment, the rise in the number of bone marrow biopsies, and increasing overall ...
- Owlstone Medical partners with Thermo Fisher Scientific for breath biopsies on November 14, 2019 at 11:34 am
Owlstone Medical last week announced that it has forged a partnership with Thermo Fisher Scientific‘s (NYSE:TMO) to advance non-invasive breath sampling in disease detection. Through the agreement, ...
- Clinical analysis reveals high expression of apoptosis protein in chemoresistant TNBC on November 13, 2019 at 11:58 am
78 TNBC biopsies from patients with different responses to chemotherapy were analysed for API-5 expression before any treatment. Further studies on API-5 expression and inhibition were performed on ...
- High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers on November 13, 2019 at 9:37 am
view more The cover for issue 61 of Oncotarget features Figure 4, "The influence of stress conditions on API-5 expression and inhibition," by Bousquet, et al. 78 TNBC biopsies from patients with ...
- Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis on November 12, 2019 at 11:36 pm
New York, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis" - ...
- Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis - 2019 Market Research Report on November 12, 2019 at 8:30 am
DUBLIN, Nov. 12, 2019 /PRNewswire/ -- The "Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis" report has been added to ResearchAndMarkets.com's offering. In the future, a variety of ...
- WATS brush effective for upper GI biopsies on October 30, 2019 at 7:01 am
SAN ANTONIO — Biopsies using a wide-area transepithelial sampling brush helped diagnose intestinal metaplasia in patients with no prior history, according to study results presented at the American ...
via Bing News